PubMed=8590302; DOI=10.1089/jir.1995.15.1005
Oka M., Hirose K., Iizuka N., Aoyagi K., Yamamoto K., Abe T., Hazama S., Suzuki T.
Cytokine mRNA expression patterns in human esophageal cancer cell lines.
J. Interferon Cytokine Res. 15:1005-1009(1995)

PubMed=8974001; DOI=10.1089/jir.1996.16.1001
Oka M., Iizuka N., Yamamoto K., Gondo T., Abe T., Hazama S., Akitomi Y., Koishihara Y., Ohsugi Y., Ooba Y., Ishihara T., Suzuki T.
The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
J. Interferon Cytokine Res. 16:1001-1006(1996)

PubMed=18575732; DOI=10.3892/or.20.1.155
Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N., Yoshino S., Hazama S.
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Oncol. Rep. 20:155-163(2008)

PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061
Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y., Kusukawa J., Kage M., Shirouzu K., Yamana H.
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Mol. Cancer Ther. 9:1842-1851(2010)